1376 completed, 386 unknown, 213 recruiting, 162 terminated. 1203 Not applicable, 232 Phase 2, 222 Phase 3, 213 Phase 4, 69 Phase 1.
Follow Urination Disorders: new trials by email Literature Review of Urination Disorders trials Research Report on Urination Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in Children Urgent PC - Overactive Bladder, Overactive Bladder Syndrome | Phase 4 | Not yet recruiting | Chi Dang Hornik | 50 | 2027-04-01 | 2026-06-17 |
| Relationship Between Insulin Dose and Complications in Type 1 Diabetes Routine/prescribed exogenous insulin dose - Diabetes Mellitus, Type 1 Diabetes, Cardiovascular Diseases (CVD) | Not yet recruiting | Rachel Miller | 80 | 2027-01-01 | 2026-11-02 | |
| Feasibility of Resisted Expiratory Muscle Training for Females Assigned at Birth With Stress Urinary Incontinence: A Pilot Study Pelvic floor muscle training, Expiratory muscle strength training - Stress Urinary Incontinence | Not applicable | Not yet recruiting | Thomas Jefferson University | 24 | 2027-01-01 | 2026-10-29 |
| Standardized 4D Transperineal Ultrasound Assessment of Urethrovesical Junction Mobility After Vaginal Laser Treatment for Stress Urinary Incontinence. Urinary Incontinence , Stress, Laser Therapy | Recruiting | Charles University, Czech Republic | 40 | 2027-01-01 | 2026-11-09 | |
| A Study of the Efficacy and Safety of Zigakibart + Atrasentan in Adult Patients With Primary IgA Nephropathy zigakibart, atrasentan, Placebo - IgA Nephropathy (IgAN) | Phase 3 | Not yet recruiting | Novartis Pharmaceuticals | 340 | 2026-12-01 | 2026-09-30 |
| Male Pelvic Floor Muscle Rehabilitation Exercises Male Pelvic Floor Rehabilitation #1 - Erectile Dysfunction, Urinary Incontinence | Not applicable | Not yet recruiting | Dream Video LLC | 100 | 2026-12-01 | 2026-10-07 |
| Long-Term Effectiveness and Safety of Sacral Neuromodulation With InterStim for Lower Urinary Tract Dysfunction InterStim™ Sacral Neuromodulation System II - X - Overactive Bladder (OAB), Urgency Urinary Incontinence | Not yet recruiting | Fundación Santa Fe de Bogota | 1700 | 2026-12-01 | 2026-10-02 | |
| Clinical, Functional, and Therapeutic Characterization of Women With Urinary Incontinence and Analysis of Factors Associated With Treatment Response Artificial intelligence clinical decision support model - Urinary Incontinence (UI) | Not yet recruiting | Javier Pereira | 80 | 2026-12-01 | 2026-11-03 | |
| A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy JADE101, Placebo - IgA Nephropathy (IgAN) | Phase 3 | Recruiting | Jade Biosciences, Inc. | 480 | 2026-12-01 | 2026-11-03 |
| Anterior Bridge-Preserving Versus Conventional Early Apical Release in Bipolar Enucleation of the Prostate Anterior Bridge-Preserving Semicircular Early Apical Release (ABP-S-EAR), Conventional Early Apical Release (EAR) - Benign Prostatic Hyperplasia, Benign Prostatic Obstruction | Not applicable | Not yet recruiting | Benha University | 230 | 2026-11-30 | 2026-10-26 |
| Anterior Bridge-Preserving Versus Conventional Early Apical Release During Holmium Laser Enucleation of the Prostate Anterior Bridge-Preserving Semicircular Early Apical Release (ABP-S-EAR), Conventional Early Apical Release (EAR) - Benign Prostatic Hyperplasia, Benign Prostatic Obstruction | Not applicable | Not yet recruiting | Ahmed Ebrahim Zahran | 230 | 2026-11-30 | 2026-10-23 |
| Obesity-Related Indices and Albuminuria in Type 2 Diabetes Obesity and Diabetes Mellitus, Type 2, Albuminuria | Not yet recruiting | Assiut University | 349 | 2026-11-10 | 2026-11-06 | |
| An Observational, Multinational, In Hospital Evaluation of Catheter Utilization Rates in Female Patients Using Indwelling Urinary Catheters and the PureWick™ Flex Female External Catheter Across Europe and the Middle East PureWick™ Flex Female External Catheter (FFEC), Indwelling Urinary Catheter (IUC) - Urinary Incontinence, Limited Mobility | Not yet recruiting | Becton, Dickinson and Company | 240 | 2026-11-06 | 2026-09-01 | |
| Transcutaneous Tibial Nerve Stimulation for Urinary Incontinence After Radical Prostatectomy Active Transcutaneous Tibial Nerve Stimulation (TTNS), Sham Transcutaneous Tibial Nerve Stimulation (TTNS), Pelvic Floor Muscle Training (PFMT) - Urinary Incontinence (UI), Prostatectomy | Not applicable | Not yet recruiting | Pamukkale University | 104 | 2026-11-01 | 2026-10-23 |
| Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery Suzetrigine, Opioid Analgesics (Tramadol or Oxycodone), Scheduled Acetaminophen and Ibuprofen - Pelvic Organ Prolapse (POP), Stress Urinary Incontinence (SUI) | Phase 4 | Not yet recruiting | University of California, Los Angeles | 120 | 2026-11-01 | 2026-09-15 |
| Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria Electronic Health Record alert - Referral and Consultation, Glomerulonephritis | Not applicable | Not yet recruiting | Geisinger Clinic | 1200 | 2026-11-01 | 2026-05-12 |
| Improving Uroflowmetry Interpretability: Evaluating the Impact of Patient Reminder Systems Patient reminder system - Pelvic Organ Prolapse, Urinary Incontinence | Not applicable | Recruiting | Ohio State University | 162 | 2026-11-01 | 2026-09-24 |
| Effectiveness of Medical and Environmental Interventions to Reduce Cystoscopy Discomfort (CystoDiscomfort) Headphones, Dwell time 5-10 minutes, Dwell Time more than 10 minutes - Bladder (Urothelial, Transitional Cell) Cancer, Hematuria | Phase 3 | Not yet recruiting | Florian Schroeck | 1740 | 2026-11-01 | 2026-09-01 |
| Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment Sex Therapy, Pelvic Floor Physical Therapy, Vacuum Erection Device (VED) - Prostate Cancer, Urinary Incontinence | Not applicable | Recruiting | Duke University | 30 | 2026-11-01 | 2026-11-06 |
| Strategy for Managing Urinary Incontinence With PRP Plasma rich platelet injection, Blood test, cytobacteriological examination of urine - Urinary Incontinence, Platelet Rich Plasma | Not applicable | Not yet recruiting | GCS Ramsay Santé pour l'Enseignement et la Recherche | 41 | 2026-10-30 | 2026-09-22 |
Showing 20 of 2427. Sign in to see all of them.
Urinary Incontinence (939) · Urinary Incontinence, Stress (648) · Proteinuria (320) · Urinary Bladder, Overactive (242) · Urinary Incontinence, Urge (241) · Urinary Retention (202) · Albuminuria (142) · Renal Insufficiency, Chronic (122) · Pelvic Organ Prolapse (99) · Nocturnal Enuresis (92) · Diabetic Nephropathies (74) · Hypertension (74) · Lower Urinary Tract Symptoms (70) · Prostatic Neoplasms (64) · Hematuria (63)
Female Urogenital Diseases and Pregnancy Complications (2426) · Male Urogenital Diseases (2426) · Urogenital Diseases (2424) · Female Urogenital Diseases (2422) · Urologic Diseases (2389) · Pathological Conditions, Signs and Symptoms (2212) · Signs and Symptoms (2135) · Urological Manifestations (2104) · Lower Urinary Tract Symptoms (1570) · Urinary Incontinence (664) · Urinary Bladder Diseases (317) · Kidney Diseases (267) · Pathologic Processes (262) · Behavior (227)
Botulinum Toxins, Type A (40) · Solifenacin Succinate (37) · Tolterodine Tartrate (30) · Suburethral Slings (29) · mirabegron (29) · Losartan (22) · Tamsulosin (21) · Transcutaneous Electric Nerve Stimulation (20) · Duloxetine Hydrochloride (19) · dapagliflozin (18) · Deamino Arginine Vasopressin (16) · Exercise (15) · Surveys and Questionnaires (15) · Biofeedback, Psychology (13) · oxybutynin (12)
Cairo University (27) · Coloplast A/S (27) · Riphah International University (20) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (19) · Eli Lilly and Company (17) · Astellas Pharma Inc (16) · University of Aarhus (15) · University of Rochester (15) · Allergan (14) · Assistance Publique - Hôpitaux de Paris (14) · Seoul National University Hospital (13) · University of California, San Francisco (13) · University of Michigan (13) · Ain Shams University (12) · VA Office of Research and Development (12)
United States (781) · Turkey (Türkiye) (206) · Canada (151) · France (145) · United Kingdom (114) · Spain (113) · China (111) · Denmark (107) · Germany (100) · Italy (93) · Egypt (89) · Brazil (73) · Netherlands (71) · Belgium (69) · Israel (64)
Kenneth Peters, MD (12) · Jeffrey B Kopp, M.D. (6) · Per Bagi, MD (6) · Fulvio Zullo, MD (5) · Seyda Toprak Celenay (5) · Stefano Palomba, MD (5) · Becky Clarkson, PhD (4)
PMID 39704322, PMID 37888839, PMID 37160401, PMID 37811598, PMID 34184246, PMID 38299639, PMID 37916745, PMID 38682786, PMID 32378735, PMID 33107592, PMID 34778952, PMID 37070660, PMID 30288727, PMID 38018702, PMID 40709601, PMID 32364251, PMID 41805697, PMID 19941278, PMID 21344495, PMID 21860294, PMID 24246044, PMID 32769645, PMID 34164803, PMID 34699062, PMID 40728007, PMID 11857671, PMID 12559262, PMID 15014933, PMID 15227649, PMID 16942457, PMID 16985862, PMID 17905093, PMID 19937315, PMID 20018326, PMID 20093904, PMID 21944127, PMID 22978814, PMID 23059770, PMID 23389863, PMID 23769122, PMID 24972732, PMID 25266357, PMID 25660356, PMID 25800900, PMID 26032537, PMID 26876327, PMID 28208214, PMID 28756065, PMID 28888814, PMID 29095516
U10HD041261 (7), U10HD041267 (7), 2016 (6), U10HD041250 (6), 2017 (5), 2019 (5), U01HD041249 (5), 2023 (4), U10HD041263 (4), U10HD054214 (4), U10HD054215 (4), 2009 (3), 2015 (3), 2025 (3), U10HD041248 (3)